Correlation Between Intra-Cellular Ther and Brooklyn Immunotherapeuti

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intra-Cellular Ther and Brooklyn Immunotherapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intra-Cellular Ther and Brooklyn Immunotherapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intra-Cellular Ther and Brooklyn Immunotherapeutics, you can compare the effects of market volatilities on Intra-Cellular Ther and Brooklyn Immunotherapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intra-Cellular Ther with a short position of Brooklyn Immunotherapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intra-Cellular Ther and Brooklyn Immunotherapeuti.

Diversification Opportunities for Intra-Cellular Ther and Brooklyn Immunotherapeuti

  Correlation Coefficient

Very good diversification

The 24 months correlation between Intra-Cellular and Brooklyn is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Intra-Cellular Ther and Brooklyn Immunotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brooklyn Immunotherapeuti and Intra-Cellular Ther is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intra-Cellular Ther are associated (or correlated) with Brooklyn Immunotherapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brooklyn Immunotherapeuti has no effect on the direction of Intra-Cellular Ther i.e., Intra-Cellular Ther and Brooklyn Immunotherapeuti go up and down completely randomly.

Pair Corralation between Intra-Cellular Ther and Brooklyn Immunotherapeuti

Given the investment horizon of 90 days Intra-Cellular Ther is expected to generate 0.34 times more return on investment than Brooklyn Immunotherapeuti. However, Intra-Cellular Ther is 2.91 times less risky than Brooklyn Immunotherapeuti. It trades about 0.05 of its potential returns per unit of risk. Brooklyn Immunotherapeutics is currently generating about -0.01 per unit of risk. If you would invest  2,600  in Intra-Cellular Ther on June 26, 2022 and sell it today you would earn a total of  1,751  from holding Intra-Cellular Ther or generate 67.35% return on investment over 90 days.
Time Period24 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Intra-Cellular Ther  vs.  Brooklyn Immunotherapeutics

 Performance (%) 
Intra-Cellular Ther 
Intra-Cellular Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Intra-Cellular Ther are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Intra-Cellular Ther may actually be approaching a critical reversion point that can send shares even higher in October 2022.

Intra-Cellular Price Channel

Brooklyn Immunotherapeuti 
Brooklyn Performance
0 of 100
Over the last 90 days Brooklyn Immunotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Brooklyn Price Channel

Intra-Cellular Ther and Brooklyn Immunotherapeuti Volatility Contrast

   Predicted Return Density   

Pair Trading with Intra-Cellular Ther and Brooklyn Immunotherapeuti

The main advantage of trading using opposite Intra-Cellular Ther and Brooklyn Immunotherapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intra-Cellular Ther position performs unexpectedly, Brooklyn Immunotherapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brooklyn Immunotherapeuti will offset losses from the drop in Brooklyn Immunotherapeuti's long position.
Intra-Cellular Ther vs. Industrias Bachoco SA
The idea behind Intra-Cellular Ther and Brooklyn Immunotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Brooklyn Immunotherapeuti vs. Nintendo Ltd ADR
Brooklyn Immunotherapeuti vs. Dena Ltd Tokyo
Brooklyn Immunotherapeuti vs. CD Projekt SA
Brooklyn Immunotherapeuti vs. Netease
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bond Directory
Find actively traded corporate debentures issued by US companies